Tomoya Fukui

<i>EGFR</i> Mutations Predict Survival Benefit From Gefitinib in Patients With Advanced Lung Adenocarcinoma: A Historical Comparison of Patients Treated Before and After Gefitinib Approval in Japan

Toshimi Takano, Tomoya Fukui, Yuichiro Ohe et al. · Journal of Clinical Oncology · 2008 · 218 citations

Detection of<i>EGFR</i>Mutations in Archived Cytologic Specimens of Non–Small Cell Lung Cancer Using High-Resolution Melting Analysis

K Nomoto, Koji Tsuta, Toshimi Takano et al. · American Journal of Clinical Pathology · 2006 · 142 citations

Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non–Small Cell Lung Cancer Treated with Gefitinib

Toshimi Takano, Yuichiro Ohe, Koji Tsuta et al. · Clinical Cancer Research · 2007 · 106 citations

Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non–Small-Cell Lung Cancer: A Prospective Observational Study

Tomoya Fukui, Yuriko Okuma, Yoshiro Nakahara et al. · Clinical Lung Cancer · 2018 · 106 citations

Prognostic Biomarkers, Cancer Immunosurveillance, Lung Inflammation +9

Prospective Study of the Accuracy of <i>EGFR</i> Mutational Analysis by High-Resolution Melting Analysis in Small Samples Obtained from Patients with Non–Small Cell Lung Cancer

Tomoya Fukui, Yuichiro Ohe, Koji Tsuta et al. · Clinical Cancer Research · 2008 · 82 citations